Common aspirin may shield cancer patients from deadly clots
NCT ID NCT06866964
Summary
This study is testing if a daily low-dose aspirin pill can prevent dangerous blood clots in men with advanced testicular or germ cell cancer who are receiving chemotherapy. The trial will enroll 35 participants at high risk for clots to take aspirin daily for 6 months while undergoing standard treatment. Researchers will compare the rate of blood clots in this group to historical data to see if aspirin provides a safe and effective preventive benefit.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERM CELL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
RECRUITINGCharlotte, North Carolina, 28204, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Aurora St. Luke's Medical Center MOB
NOT_YET_RECRUITINGMilwaukee, Wisconsin, 53215, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Wake Forest Baptist Comprehensive Cancer Center
RECRUITINGWinston-Salem, North Carolina, 27157, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.